nodes	percent_of_prediction	percent_of_DWPC	metapath
Capreomycin—Ototoxicity—Thiotepa—sarcoma	0.109	0.109	CcSEcCtD
Capreomycin—Induration—Etoposide—sarcoma	0.0353	0.0353	CcSEcCtD
Capreomycin—Urine abnormality—Mitoxantrone—sarcoma	0.0343	0.0343	CcSEcCtD
Capreomycin—Nephropathy toxic—Mitoxantrone—sarcoma	0.033	0.033	CcSEcCtD
Capreomycin—Injection site haemorrhage—Epirubicin—sarcoma	0.0329	0.0329	CcSEcCtD
Capreomycin—Urine analysis abnormal—Mitoxantrone—sarcoma	0.0323	0.0323	CcSEcCtD
Capreomycin—Injection site haemorrhage—Doxorubicin—sarcoma	0.0304	0.0304	CcSEcCtD
Capreomycin—Nephropathy toxic—Etoposide—sarcoma	0.0275	0.0275	CcSEcCtD
Capreomycin—Oliguria—Thiotepa—sarcoma	0.0238	0.0238	CcSEcCtD
Capreomycin—Hypocalcaemia—Dactinomycin—sarcoma	0.0238	0.0238	CcSEcCtD
Capreomycin—Hearing impaired—Thiotepa—sarcoma	0.0231	0.0231	CcSEcCtD
Capreomycin—Hypocalcaemia—Mitoxantrone—sarcoma	0.0207	0.0207	CcSEcCtD
Capreomycin—Deafness—Thiotepa—sarcoma	0.0178	0.0178	CcSEcCtD
Capreomycin—Urine abnormality—Epirubicin—sarcoma	0.016	0.016	CcSEcCtD
Capreomycin—Deafness—Vincristine—sarcoma	0.0158	0.0158	CcSEcCtD
Capreomycin—Urine analysis abnormal—Epirubicin—sarcoma	0.015	0.015	CcSEcCtD
Capreomycin—Urine abnormality—Doxorubicin—sarcoma	0.0148	0.0148	CcSEcCtD
Capreomycin—Hypomagnesaemia—Epirubicin—sarcoma	0.0139	0.0139	CcSEcCtD
Capreomycin—Urine analysis abnormal—Doxorubicin—sarcoma	0.0139	0.0139	CcSEcCtD
Capreomycin—Hypomagnesaemia—Doxorubicin—sarcoma	0.0129	0.0129	CcSEcCtD
Capreomycin—Hypokalaemia—Mitoxantrone—sarcoma	0.0125	0.0125	CcSEcCtD
Capreomycin—Renal failure—Thiotepa—sarcoma	0.0121	0.0121	CcSEcCtD
Capreomycin—Abscess—Epirubicin—sarcoma	0.0112	0.0112	CcSEcCtD
Capreomycin—Renal failure—Mitoxantrone—sarcoma	0.0104	0.0104	CcSEcCtD
Capreomycin—Abscess—Doxorubicin—sarcoma	0.0103	0.0103	CcSEcCtD
Capreomycin—Tinnitus—Thiotepa—sarcoma	0.0103	0.0103	CcSEcCtD
Capreomycin—Hypocalcaemia—Epirubicin—sarcoma	0.00966	0.00966	CcSEcCtD
Capreomycin—Oliguria—Epirubicin—sarcoma	0.0096	0.0096	CcSEcCtD
Capreomycin—Hypocalcaemia—Doxorubicin—sarcoma	0.00894	0.00894	CcSEcCtD
Capreomycin—Oliguria—Doxorubicin—sarcoma	0.00888	0.00888	CcSEcCtD
Capreomycin—Hepatocellular injury—Epirubicin—sarcoma	0.00885	0.00885	CcSEcCtD
Capreomycin—Renal failure—Etoposide—sarcoma	0.00868	0.00868	CcSEcCtD
Capreomycin—Leukopenia—Thiotepa—sarcoma	0.0086	0.0086	CcSEcCtD
Capreomycin—Leukopenia—Dactinomycin—sarcoma	0.00853	0.00853	CcSEcCtD
Capreomycin—Hepatocellular injury—Doxorubicin—sarcoma	0.00819	0.00819	CcSEcCtD
Capreomycin—Thrombocytopenia—Thiotepa—sarcoma	0.00768	0.00768	CcSEcCtD
Capreomycin—Vertigo—Vincristine—sarcoma	0.00765	0.00765	CcSEcCtD
Capreomycin—Leukopenia—Vincristine—sarcoma	0.00762	0.00762	CcSEcCtD
Capreomycin—Thrombocytopenia—Dactinomycin—sarcoma	0.00762	0.00762	CcSEcCtD
Capreomycin—Leukopenia—Mitoxantrone—sarcoma	0.00743	0.00743	CcSEcCtD
Capreomycin—Thrombocytopenia—Vincristine—sarcoma	0.00681	0.00681	CcSEcCtD
Capreomycin—Renal impairment—Epirubicin—sarcoma	0.00675	0.00675	CcSEcCtD
Capreomycin—Pain—Thiotepa—sarcoma	0.0067	0.0067	CcSEcCtD
Capreomycin—Pain—Dactinomycin—sarcoma	0.00665	0.00665	CcSEcCtD
Capreomycin—Thrombocytopenia—Mitoxantrone—sarcoma	0.00663	0.00663	CcSEcCtD
Capreomycin—Renal impairment—Doxorubicin—sarcoma	0.00624	0.00624	CcSEcCtD
Capreomycin—Urticaria—Thiotepa—sarcoma	0.00623	0.00623	CcSEcCtD
Capreomycin—Vertigo—Etoposide—sarcoma	0.0062	0.0062	CcSEcCtD
Capreomycin—Body temperature increased—Thiotepa—sarcoma	0.0062	0.0062	CcSEcCtD
Capreomycin—Leukopenia—Etoposide—sarcoma	0.00618	0.00618	CcSEcCtD
Capreomycin—Body temperature increased—Dactinomycin—sarcoma	0.00615	0.00615	CcSEcCtD
Capreomycin—Pain—Vincristine—sarcoma	0.00594	0.00594	CcSEcCtD
Capreomycin—Hypokalaemia—Epirubicin—sarcoma	0.00585	0.00585	CcSEcCtD
Capreomycin—Pain—Mitoxantrone—sarcoma	0.00579	0.00579	CcSEcCtD
Capreomycin—Hypersensitivity—Thiotepa—sarcoma	0.00578	0.00578	CcSEcCtD
Capreomycin—Hypersensitivity—Dactinomycin—sarcoma	0.00573	0.00573	CcSEcCtD
Capreomycin—Thrombocytopenia—Etoposide—sarcoma	0.00551	0.00551	CcSEcCtD
Capreomycin—Eosinophilia—Epirubicin—sarcoma	0.0055	0.0055	CcSEcCtD
Capreomycin—Body temperature increased—Vincristine—sarcoma	0.0055	0.0055	CcSEcCtD
Capreomycin—Hypokalaemia—Doxorubicin—sarcoma	0.00541	0.00541	CcSEcCtD
Capreomycin—Urticaria—Mitoxantrone—sarcoma	0.00538	0.00538	CcSEcCtD
Capreomycin—Body temperature increased—Mitoxantrone—sarcoma	0.00535	0.00535	CcSEcCtD
Capreomycin—Hypersensitivity—Vincristine—sarcoma	0.00512	0.00512	CcSEcCtD
Capreomycin—Eosinophilia—Doxorubicin—sarcoma	0.00509	0.00509	CcSEcCtD
Capreomycin—Hypersensitivity—Mitoxantrone—sarcoma	0.00499	0.00499	CcSEcCtD
Capreomycin—Rash—Thiotepa—sarcoma	0.00494	0.00494	CcSEcCtD
Capreomycin—Dermatitis—Thiotepa—sarcoma	0.00494	0.00494	CcSEcCtD
Capreomycin—Rash—Dactinomycin—sarcoma	0.00491	0.00491	CcSEcCtD
Capreomycin—Renal failure—Epirubicin—sarcoma	0.00487	0.00487	CcSEcCtD
Capreomycin—Pain—Etoposide—sarcoma	0.00482	0.00482	CcSEcCtD
Capreomycin—Renal failure—Doxorubicin—sarcoma	0.0045	0.0045	CcSEcCtD
Capreomycin—Urticaria—Etoposide—sarcoma	0.00447	0.00447	CcSEcCtD
Capreomycin—Body temperature increased—Etoposide—sarcoma	0.00445	0.00445	CcSEcCtD
Capreomycin—Rash—Vincristine—sarcoma	0.00438	0.00438	CcSEcCtD
Capreomycin—Dermatitis—Vincristine—sarcoma	0.00438	0.00438	CcSEcCtD
Capreomycin—Rash—Mitoxantrone—sarcoma	0.00427	0.00427	CcSEcCtD
Capreomycin—Dermatitis—Mitoxantrone—sarcoma	0.00426	0.00426	CcSEcCtD
Capreomycin—Hypersensitivity—Etoposide—sarcoma	0.00415	0.00415	CcSEcCtD
Capreomycin—Tinnitus—Epirubicin—sarcoma	0.00414	0.00414	CcSEcCtD
Capreomycin—Tinnitus—Doxorubicin—sarcoma	0.00383	0.00383	CcSEcCtD
Capreomycin—Rash—Etoposide—sarcoma	0.00355	0.00355	CcSEcCtD
Capreomycin—Dermatitis—Etoposide—sarcoma	0.00355	0.00355	CcSEcCtD
Capreomycin—Vertigo—Epirubicin—sarcoma	0.00347	0.00347	CcSEcCtD
Capreomycin—Leukopenia—Epirubicin—sarcoma	0.00346	0.00346	CcSEcCtD
Capreomycin—Vertigo—Doxorubicin—sarcoma	0.00322	0.00322	CcSEcCtD
Capreomycin—Leukopenia—Doxorubicin—sarcoma	0.0032	0.0032	CcSEcCtD
Capreomycin—Thrombocytopenia—Epirubicin—sarcoma	0.00309	0.00309	CcSEcCtD
Capreomycin—Thrombocytopenia—Doxorubicin—sarcoma	0.00286	0.00286	CcSEcCtD
Capreomycin—Pain—Epirubicin—sarcoma	0.0027	0.0027	CcSEcCtD
Capreomycin—Urticaria—Epirubicin—sarcoma	0.00251	0.00251	CcSEcCtD
Capreomycin—Pain—Doxorubicin—sarcoma	0.0025	0.0025	CcSEcCtD
Capreomycin—Body temperature increased—Epirubicin—sarcoma	0.0025	0.0025	CcSEcCtD
Capreomycin—Hypersensitivity—Epirubicin—sarcoma	0.00233	0.00233	CcSEcCtD
Capreomycin—Urticaria—Doxorubicin—sarcoma	0.00232	0.00232	CcSEcCtD
Capreomycin—Body temperature increased—Doxorubicin—sarcoma	0.00231	0.00231	CcSEcCtD
Capreomycin—Hypersensitivity—Doxorubicin—sarcoma	0.00215	0.00215	CcSEcCtD
Capreomycin—Rash—Epirubicin—sarcoma	0.00199	0.00199	CcSEcCtD
Capreomycin—Dermatitis—Epirubicin—sarcoma	0.00199	0.00199	CcSEcCtD
Capreomycin—Rash—Doxorubicin—sarcoma	0.00184	0.00184	CcSEcCtD
Capreomycin—Dermatitis—Doxorubicin—sarcoma	0.00184	0.00184	CcSEcCtD
